We came upon the article titled "The Role of Medications in Causing Dry Eye" \[[@B1]\], during a recent literature search conducted for a continuing education program we recently produced on the management of dry eye disease.

In reviewing this article, we noted a number of errors, particularly in Tables 3 and 4. Specifically, many of the drugs are misclassified and/or allocated to incorrect therapeutic drug classes, and accordingly, corrigendum has been published.

Please also note the following errors:Anti-arrhythmic was misspelled in the publication ("antiarrythmic")Hyoscine methobromide was listed as an alternate name for methscopolamine, but these two agents are not equivalentChlorthalidone was misspelled in the publication ("chlortalidone")

Please also note that we did not review the literature behind the drugs listed under "drugs secreted in tears" and are therefore unable to validate these claims.

While we do not question the likelihood that these medications may cause or aggravate dry eye, the fact that they are not appropriately classified or identified may lead to unintentional errors or misconceptions by practitioners, students, or patients not familiar with these medications.

As this article has been cited by a number of other papers in the relevant literature, we appreciate your attention to the content updates provided.

Our project focuses on interprofessional collaboration between pharmacists and eye care professionals, and in that spirit, we hope that this information is of value to you.

The list of our findings is presented in [Table 3](#tab3){ref-type="table"}.

The list of our findings is presented in [Table 4](#tab4){ref-type="table"}.
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###### 

Systemic drugs probably causing or aggravating dry eyes.

  Drug name                Drug class listed in publication   Actual drug class
  ------------------------ ---------------------------------- ----------------------------------------------------------------------
  Acebutolol               Beta-agonist                       Beta-blocker with intrinsic sympathomimetic activity
  Alfuzosin                Antiandrogen                       Alpha~1~-blocker
  Atenolol                 Alpha-agonist                      Beta-blocker
  Atropine                 Anti-arrhythmic                    Anticholinergic; ophthalmic agent, mydriatic
  Brompheniramine          Antipsychotic                      Histamine H~1~-antagonist, first generation
  Chlorpheniramine         Antipsychotic                      Histamine H~1~-antagonist, first generation
  Chlorthalidone           Thiazide                           Diuretic, thiazide-related
  Clemastine               Antipsychotic                      Histamine H~1~-antagonist, first generation
  Clofazimine              Antileprosy                        Antibiotic
  Clonidine                Beta-blocker                       Alpha~2~-adrenergic agonist
  Cyproheptadine           Antipsychotic                      Histamine H~1~-antagonist, first generation
  Dexchlorpheniramine      Antipsychotic                      Histamine H~1~-antagonist, first generation
  Diphenhydramine          Bronchodilator                     Histamine H~1~-antagonist, first generation
  Doxazosin                Antiandrogen                       Alpha~1~-blocker
  Doxylamine               Antispasmodic/antimuscarinic       Histamine H~1~-antagonist, first generation; ethanolamine derivative
  Dronabinol               Cannabinoids                       Antiemetic; appetite stimulant
  Homatropine              Anti-arrhythmic                    Anticholinergic; ophthalmic agent, mydriatic
  Hyoscine (scopolamine)   Anti-arrhythmic                    Anticholinergic; ophthalmic agent, mydriatic
  Hyoscine methobromide    Anti-arrhythmic                    Antimuscarinic/antispasmodic
  Indapamide               Thiazide                           Diuretic, thiazide-related
  Ipratropium              Anti-arrhythmic                    Anticholinergic
  Metolazone               Thiazide                           Diuretic, thiazide-related
  Prazosin                 Anti-arrhythmic; beta-blocker      Alpha~1~-blocker
  Primidone                Sedative and hypnotic              Anticonvulsant; barbiturate
  Promethazine             Antipsychotic                      Histamine H~1~-antagonist, first generation
  Tamsulosin               Antiandrogen                       Alpha~1~-blocker
  Terazosin                Antiandrogen                       Alpha~1~-blocker
  Tolterodine              Anti-arrhythmic                    Anticholinergic

###### 

Topical ocular drugs that may cause or aggravate dry eye.

  Drug name                  Drug class listed in publication   Actual drug class
  -------------------------- ---------------------------------- -------------------------------------------------------------
  Apraclonidine              Adrenergic agonist                 Alpha~2~-agonist
  Brimonidine (ophthalmic)   Adrenergic agonist                 Alpha~2~-agonist; antiglaucoma
  Dapiprazole                Miotic                             Alpha-blocker
  Dipivefrine                Prostaglandin                      Prodrug of epinephrine
  Naphazoline (ophthalmic)   Decongestant                       Alpha~1~-agonist; vasoconstrictor; imidazoline derivative
  Tetryzoline (ophthalmic)   Decongestant                       Adrenergic agonist; vasoconstrictor; imidazoline derivative
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